Epidemiology of staphylococcal resistance
- PMID:17712743
- DOI: 10.1086/519473
Epidemiology of staphylococcal resistance
Abstract
An understanding of the prevalence of resistant Staphylococcus aureus and the risk factors for infection with resistant isolates is essential to help clinicians choose appropriate antibiotic therapy. Selection pressure due to prior and inappropriate antibiotic use of any kind seems to be the main driving force behind the increasing rates of multidrug resistance in methicillin-resistant S. aureus (MRSA) strains. Resistance to glycopeptide antibiotics in MRSA has also emerged in recent years, along with increased use of vancomycin to treat serious infections due to MRSA. Infections due to MRSA are associated with significantly increased morbidity, mortality, length of hospital stay, and costs, compared with infections due to methicillin-susceptible S. aureus, despite adjustment for disease severity and initially appropriate antibiotic treatment. Improvements in the preparation and dissemination of antibiograms, along with adequate public reporting of MRSA trends, are needed to address the challenge of choosing appropriate initial antibiotic treatment for MRSA infections.
Similar articles
- Microbiology of antibiotic resistance in Staphylococcus aureus.Appelbaum PC.Appelbaum PC.Clin Infect Dis. 2007 Sep 15;45 Suppl 3:S165-70. doi: 10.1086/519474.Clin Infect Dis. 2007.PMID:17712742Review.
- Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.Sakoulas G, Moellering RC Jr.Sakoulas G, et al.Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S360-7. doi: 10.1086/533592.Clin Infect Dis. 2008.PMID:18462091Review.
- Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005.Asbell PA, Sahm DF, Shaw M, Draghi DC, Brown NP.Asbell PA, et al.J Cataract Refract Surg. 2008 May;34(5):814-8. doi: 10.1016/j.jcrs.2008.01.016.J Cataract Refract Surg. 2008.PMID:18471638
- Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.Viallon A, Marjollet O, Berthelot P, Carricajo A, Guyomarc'h S, Robert F, Zeni F, Bertrand JC.Viallon A, et al.Am J Emerg Med. 2007 Oct;25(8):880-6. doi: 10.1016/j.ajem.2007.01.013.Am J Emerg Med. 2007.PMID:17920971
- Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).Appelbaum PC.Appelbaum PC.Int J Antimicrob Agents. 2007 Nov;30(5):398-408. doi: 10.1016/j.ijantimicag.2007.07.011. Epub 2007 Sep 20.Int J Antimicrob Agents. 2007.PMID:17888634Review.
Cited by
- Nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction: a potential use in guiding antibiotic therapy for pneumonia.Johnson JA, Wright ME, Sheperd LA, Musher DM, Dang BN.Johnson JA, et al.Perm J. 2015 Winter;19(1):34-6. doi: 10.7812/TPP/14-101. Epub 2014 Nov 24.Perm J. 2015.PMID:25432002Free PMC article.
- Antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated at tertiary care hospital in Riyadh, Saudi Arabia.Al-Sarar D, Moussa IM, Alhetheel A.Al-Sarar D, et al.Medicine (Baltimore). 2024 Apr 19;103(16):e37860. doi: 10.1097/MD.0000000000037860.Medicine (Baltimore). 2024.PMID:38640320Free PMC article.
- Resistant Bacteria in Broiler Litter Used as Ruminant Feed: Effect of Biotic Treatment.Efriem S, Sabastian C, Blum S, Fleker M, Mabjeesh SJ, Britzi M.Efriem S, et al.Antibiotics (Basel). 2023 Jun 23;12(7):1093. doi: 10.3390/antibiotics12071093.Antibiotics (Basel). 2023.PMID:37508189Free PMC article.
- Efficacy of Novel Antistaphylococcal Ectolysin P128 in a Rat Model of Methicillin-Resistant Staphylococcus aureus Bacteremia.Channabasappa S, Durgaiah M, Chikkamadaiah R, Kumar S, Joshi A, Sriram B.Channabasappa S, et al.Antimicrob Agents Chemother. 2018 Jan 25;62(2):e01358-17. doi: 10.1128/AAC.01358-17. Print 2018 Feb.Antimicrob Agents Chemother. 2018.PMID:29180523Free PMC article.
- Hospital-Acquired Methicillin-resistantStaphylococcus aureus Bacteremia Related to Medicare Antibiotic Prescriptions: A State-Level Analysis.Fukunaga BT, Sumida WK, Taira DA, Davis JW, Seto TB.Fukunaga BT, et al.Hawaii J Med Public Health. 2016 Oct;75(10):303-309.Hawaii J Med Public Health. 2016.PMID:27738564Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical